GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » E10

Rapid Dose Therapeutics (XCNQ:DOSE) E10 : C$-0.09 (As of Nov. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Rapid Dose Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Rapid Dose Therapeutics's adjusted earnings per share data for the three months ended in Nov. 2024 was C$-0.010. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is C$-0.09 for the trailing ten years ended in Nov. 2024.

During the past 3 years, the average E10 Growth Rate was 23.40% per year. During the past 5 years, the average E10 Growth Rate was 31.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Rapid Dose Therapeutics was 44.10% per year. The lowest was 12.00% per year. And the median was 23.40% per year.

As of today (2025-03-31), Rapid Dose Therapeutics's current stock price is C$0.20. Rapid Dose Therapeutics's E10 for the quarter that ended in Nov. 2024 was C$-0.09. Rapid Dose Therapeutics's Shiller PE Ratio of today is .


Rapid Dose Therapeutics E10 Historical Data

The historical data trend for Rapid Dose Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics E10 Chart

Rapid Dose Therapeutics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.22 -0.20 -0.18 -0.15 -0.09

Rapid Dose Therapeutics Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.09 -0.09 -0.09 -0.09 -0.09

Competitive Comparison of Rapid Dose Therapeutics's E10

For the Biotechnology subindustry, Rapid Dose Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapid Dose Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's Shiller PE Ratio falls into.


;
;

Rapid Dose Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Rapid Dose Therapeutics's adjusted earnings per share data for the three months ended in Nov. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Nov. 2024 (Change)*Current CPI (Nov. 2024)
=-0.01/127.8378*127.8378
=-0.010

Current CPI (Nov. 2024) = 127.8378.

Rapid Dose Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201406 -0.080 99.473 -0.103
201409 0.066 99.394 0.085
201412 -0.030 98.367 -0.039
201503 -0.010 99.789 -0.013
201506 -0.010 100.500 -0.013
201509 -0.070 100.421 -0.089
201512 -0.015 99.947 -0.019
201603 -0.015 101.054 -0.019
201606 -0.015 102.002 -0.019
201609 -0.015 101.765 -0.019
201612 -0.015 101.449 -0.019
201703 -0.005 102.634 -0.006
201706 -0.005 103.029 -0.006
201709 -0.030 103.345 -0.037
201712 -0.015 103.345 -0.019
201809 0.000 105.636 0.000
201902 -0.150 106.268 -0.180
201905 -0.040 107.927 -0.047
201908 -0.010 108.085 -0.012
201911 -0.040 107.769 -0.047
202002 -0.010 108.559 -0.012
202005 -0.010 107.532 -0.012
202008 -0.005 108.243 -0.006
202011 -0.010 108.796 -0.012
202102 -0.004 109.745 -0.005
202105 -0.002 111.404 -0.002
202108 -0.010 112.668 -0.011
202111 -0.008 113.932 -0.009
202202 -0.065 115.986 -0.072
202205 -0.010 120.016 -0.011
202208 -0.010 120.569 -0.011
202211 -0.006 121.675 -0.006
202302 -0.016 122.070 -0.017
202305 -0.010 124.045 -0.010
202308 -0.010 125.389 -0.010
202311 -0.010 125.468 -0.010
202402 -0.010 125.468 -0.010
202405 -0.010 127.601 -0.010
202408 -0.010 127.838 -0.010
202411 -0.010 127.838 -0.010

Add all the adjusted EPS together and divide 10 will get our e10.


Rapid Dose Therapeutics  (XCNQ:DOSE) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Rapid Dose Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Rapid Dose Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
Executives
Mark Upsdell Director
Brian Howlett Director

Rapid Dose Therapeutics Headlines

No Headlines